• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    2/10/23 1:22:43 PM ET
    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Beverages (Production/Distribution)
    Consumer Staples
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABEV alert in real time by email

     

    During Friday, 48 stocks hit new 52-week lows.

    Key Facts About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Ambev (NYSE:ABEV).
    • Reshape Lifesciences (NASDAQ:RSLS) was the smallest company when considering market cap to set a new 52-week low.
    • Soligenix (NASDAQ:SNGX) shares traded down 1193.45% to reach its 52-week low, making it the biggest loser.
    • Vertical Aerospace (NYSE:EVTL) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    The stocks that set new 52-week lows on Friday:

    • Ambev (NYSE:ABEV) stock achieved a new 52-week low on Friday morning, hitting $2.41 and moving down 1.43%.
    • Bank Bradesco (NYSE:BBD) stock hit a yearly low of $2.43. The stock was down 6.98% for the day.
    • Sirius XM Holdings (NASDAQ:SIRI) shares were down 0.42% for the day, having made a 52-week low of $4.72.
    • Hanesbrands (NYSE:HBI) shares set a new 52-week low of $5.60. The stock traded down 0.79%.
    • Sterling Check (NASDAQ:STER) shares set a new yearly low of $11.92 this morning. The stock was down 11.46% on the session.
    • Cronos Group (NASDAQ:CRON) shares made a new 52-week low of $2.26 on Friday. The stock was down 1.72% for the day.
    • Mercer Intl (NASDAQ:MERC) shares fell to $10.55 on Friday, setting a new 52-week low with a shift of down 10.52%.
    • Azul (NYSE:AZUL) stock hit $5.19 on Friday morning, setting a new 52-week low for a change of down 4.59%.
    • Vertical Aerospace (NYSE:EVTL) stock hit a yearly low of $1.94. The stock was 0.0% (flat) for the day.
    • Bridger Aerospace Gr (NASDAQ:BAER) stock hit a new 52-week low of $3.77. The stock was down 2.18% on the session.
    • Guaranty Bancshares (NASDAQ:GNTY) shares hit a yearly low of $31.10. The stock was up 0.09% on the session.
    • Hyzon Motors (NASDAQ:HYZN) shares reached a new 52-week low of $1.25 on Friday morning, moving down 23.94%.
    • Tupperware Brands (NYSE:TUP) shares reached a new 52-week low of $3.72 on Friday morning, moving down 1.28%.
    • Cerberus Cyber Sentinel (NASDAQ:CISO) shares fell to $1.10 on Friday, setting a new 52-week low with a shift of down 6.38%.
    • GreenLight Biosciences (NASDAQ:GRNA) stock hit $0.86 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • AERWINS Technologies (NASDAQ:AWIN) stock hit a yearly low of $2.04. The stock was down 6.11% for the day.
    • Clough Global Equity (AMEX:GLQ) shares hit a yearly low of $6.14. The stock was up 0.33% on the session.
    • Vintage Wine Estates (NASDAQ:VWE) stock achieved a new 52-week low on Friday morning, hitting $1.85 and moving down 5.48%.
    • Heliogen (NYSE:HLGN) stock set a new 52-week low of $0.38 on Friday, moving down 8.33%.
    • NeoVolta (NASDAQ:NEOV) shares set a new yearly low of $1.96 this morning. The stock was down 7.11% on the session.
    • Taysha Gene Therapies (NASDAQ:TSHA) stock broke to a new 52-week low of $1.02 on Friday. Shares of the company traded down 2.38%.
    • P3 Health Partners (NASDAQ:PIII) stock achieved a new 52-week low on Friday morning, hitting $1.05 and moving down 4.0%.
    • 9F (NASDAQ:JFU) stock dropped to a yearly low on Friday of $3.13. Shares traded down 8.92%.
    • Ascent Solar Technologies (NASDAQ:ASTI) shares moved down 2.09% on Friday to hit a new 52-week low of $0.80, drifting down 2.09%.
    • MGO Global (NASDAQ:MGOL) shares set a new 52-week low of $1.79. The stock traded down 9.05%.
    • Cadrenal Therapeutics (NASDAQ:CVKD) stock broke to a new 52-week low of $1.86 on Friday. Shares of the company traded down 0.1%.
    • CN Energy Group (NASDAQ:CNEY) shares set a new yearly low of $0.41 this morning. The stock was down 6.33% on the session.
    • Can Fite Biofarma (AMEX:CANF) shares set a new yearly low of $3.35 this morning. The stock was down 4.23% on the session.
    • WiSA Technologies (NASDAQ:WISA) stock achieved a new 52-week low on Friday morning, hitting $5.99 and moving down 4.31%.
    • Tenax Therapeutics (NASDAQ:TENX) shares fell to $1.03 on Friday, setting a new 52-week low with a shift of down 2.73%.
    • Panbela Therapeutics (NASDAQ:PBLA) shares reached a new 52-week low of $1.23 on Friday morning, moving down 7.95%.
    • OceanPal (NASDAQ:OP) stock hit a new 52-week low of $0.62. The stock was down 10.98% on the session.
    • OpGen (NASDAQ:OPGN) stock hit a new 52-week low of $1.45. The stock was down 4.97% on the session.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $0.18 on Friday morning, moving down 1.76%.
    • Reshape Lifesciences (NASDAQ:RSLS) shares hit a yearly low of $5.10. The stock was down 5.06% on the session.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ABEV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABEV
    $ALLR
    $ASTI
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Tenax Therapeutics Inc.
    $TENX
    9/8/2025$20.00Overweight
    Piper Sandler
    P3 Health Partners Inc.
    $PIII
    8/28/2025$20.00Buy
    Lake Street
    Vertical Aerospace Ltd.
    $EVTL
    8/22/2025$8.00Overweight
    Cantor Fitzgerald
    Ambev S.A.
    $ABEV
    8/1/2025Buy → Hold
    HSBC Securities
    Allarity Therapeutics Inc.
    $ALLR
    7/28/2025$9.00Buy
    Ascendiant Capital Markets
    Vertical Aerospace Ltd.
    $EVTL
    7/17/2025$9.00Buy
    Needham
    Taysha Gene Therapies Inc.
    $TSHA
    7/11/2025$8.00Buy
    BofA Securities
    Azul S.A.
    $AZUL
    5/15/2025Outperform → Mkt Perform
    Raymond James
    More analyst ratings

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on Tenax Therapeutics with a new price target

    Piper Sandler initiated coverage of Tenax Therapeutics with a rating of Overweight and set a new price target of $20.00

    9/8/25 8:59:21 AM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lake Street resumed coverage on P3 Health Partners with a new price target

    Lake Street resumed coverage of P3 Health Partners with a rating of Buy and set a new price target of $20.00

    8/28/25 8:10:21 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Cantor Fitzgerald initiated coverage on Vertical Aerospace Group with a new price target

    Cantor Fitzgerald initiated coverage of Vertical Aerospace Group with a rating of Overweight and set a new price target of $8.00

    8/22/25 8:02:13 AM ET
    $EVTL
    Aerospace
    Industrials

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    SEC Filings

    View All

    SEC Form F-3 filed by OceanPal Inc.

    F-3 - OceanPal Inc. (0001869467) (Filer)

    9/16/25 4:51:04 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Tenax Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - TENAX THERAPEUTICS, INC. (0000034956) (Filer)

    9/16/25 8:10:27 AM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cadrenal Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer)

    9/15/25 9:53:55 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ascent Solar Enters Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities

    THORNTON, Colo., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies ("Ascent" or the "Company"), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today announced the signing of a teaming agreement with Emtel Energy USA ("Emtel Energy"), a provider of graphene-based electrostatic long duration energy storage (ELDES). The agreement is intended to achieve mutually beneficial goals that would advance Emtel Energy's energy storage capabilities and aid the proliferation of thin-film PV solutions in space environments. Emtel Energy has developed a high-agility solid-state graphene battery alternative that circu

    9/16/25 8:00:00 AM ET
    $ASTI
    Semiconductors
    Technology

    Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

    Provides Patent Protection in Europe Through at Least December 2040 Further IP Protection for TNX-103 (Oral Levosimendan) and Other Drug Formulations, and its Active Metabolites, in PH-HFpEF Also Provides Patent Protection for Wide Range of Levosimendan Doses, and its Use in Combination with Various Cardiovascular Drugs in PH-HFpEF CHAPEL HILL, N.C., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (NASDAQ:TENX) ("Tenax" or "Tenax Therapeutics" or the "Company"), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that the European Patent Office (EPO) has notified Tenax of its Intention to Gra

    9/16/25 7:00:00 AM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera's Portfolio of Factor XIa Inhibitors

    Acquisition significantly enhances the Company's pipeline by adding novel assets in acute and chronic anticoagulation settingsCompany is strategically poised to deliver differentiated therapeutics across the spectrum of cardiovascular thrombotic risk PONTE VEDRA, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced the acquisition of the assets of eXIthera Pharmaceuticals ("eXIthera"), including its proprietary portfolio of investigational intravenous (IV) and oral Factor XIa inhibitors. The acquisition significantly enhances Ca

    9/15/25 8:00:00 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Welty Linda J bought $30,866 worth of shares (10,000 units at $3.09), increasing direct ownership by 38% to 36,290 units (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    8/19/25 12:23:28 PM ET
    $MERC
    Paper
    Basic Materials

    Director Laberge Alice bought $5,957 worth of shares (2,000 units at $2.98), increasing direct ownership by 20% to 12,065 units (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    8/8/25 5:50:55 PM ET
    $MERC
    Paper
    Basic Materials

    Director Laberge Alice bought $5,980 worth of shares (2,000 units at $2.99), increasing direct ownership by 25% to 10,065 units (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    8/8/25 1:10:16 PM ET
    $MERC
    Paper
    Basic Materials

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and Head of R&D Nagendran Sukumar exercised 41,150 shares at a strike of $0.70 and sold $646,000 worth of shares (200,000 units at $3.23), decreasing direct ownership by 14% to 1,006,439 units (SEC Form 4)

    4 - Taysha Gene Therapies, Inc. (0001806310) (Issuer)

    9/12/25 4:15:25 PM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Financial Officer Szot Matthew K sold $27,992 worth of shares (2,000 units at $14.00), decreasing direct ownership by 6% to 31,333 units (SEC Form 4)

    4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    8/29/25 8:35:16 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO and Chairman Pham Quang X sold $70,356 worth of shares (5,029 units at $13.99), decreasing direct ownership by 2% to 213,304 units (SEC Form 4)

    4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    8/29/25 8:34:51 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Vertical Aerospace Prepares for Final Transition Testing After Successful Wingborne Flights

    Phase 3 wingborne testing completed with full-scale VX4 prototype, demonstrating stable and efficient flight on the wing Aircraft exceeded expectations across piloted flight tests covering 250 miles / 400 km, collecting over 22 billion data points Final flight test stage - transition - now underway, targeted for completion by year-end Progress reflects continued regulator confidence as Vertical advances toward type certification in 2028 More detail to be shared at Vertical's Capital Markets Day, 17 September, New York Vertical Aerospace (Vertical) (NYSE:EVTL), a global aerospace and technology company pioneering electric aviation, today announced the successful completion of

    9/9/25 6:00:00 AM ET
    $EVTL
    Aerospace
    Industrials

    Dave Stephenson Joins SiriusXM's Board of Directors

    NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Sirius XM Holdings Inc. (NASDAQ:SIRI) today announced the appointment of a new independent director, Dave Stephenson, to the company's Board of Directors, effective September 18, 2025. He will serve on the Board's compensation committee. Stephenson is a seasoned business executive, with deep leadership experience at some of the largest global technology companies. He currently serves as Chief Business Officer and Head of Employee Experience for Airbnb, Inc. (NASDAQ:ABNB), where he is responsible for Airbnb's global business growth and th

    9/8/25 8:00:00 AM ET
    $ABNB
    $SIRI
    Diversified Commercial Services
    Consumer Discretionary
    Broadcasting

    Patrick Ky, Former EASA Executive Director, Joins Vertical Aerospace's Board

    Former Executive Director of the European Union Aviation Safety Agency (EASA) brings unrivalled global regulatory experience Appointment reinforces Vertical's pathway to certify its VX4 aircraft in 2028 with the UK Civil Aviation Authority (CAA) and EASA European certification of eVTOLs will be to the highest aviation safety standard globally, supporting global portability of this certification to other regulators thereafter Vertical Aerospace (Vertical) (NYSE:EVTL), a global aerospace and technology company that is pioneering electric aviation, today announced the appointment of Patrick Ky to its Board of Directors, strengthening the company's regulatory expertise and leadership

    9/2/25 7:01:00 PM ET
    $EVTL
    Aerospace
    Industrials

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Azul S.A.

    SC 13G - AZUL SA (0001432364) (Subject)

    12/6/24 4:26:59 PM ET
    $AZUL
    Air Freight/Delivery Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:17:41 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Financials

    Live finance-specific insights

    View All

    Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera's Portfolio of Factor XIa Inhibitors

    Acquisition significantly enhances the Company's pipeline by adding novel assets in acute and chronic anticoagulation settingsCompany is strategically poised to deliver differentiated therapeutics across the spectrum of cardiovascular thrombotic risk PONTE VEDRA, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced the acquisition of the assets of eXIthera Pharmaceuticals ("eXIthera"), including its proprietary portfolio of investigational intravenous (IV) and oral Factor XIa inhibitors. The acquisition significantly enhances Ca

    9/15/25 8:00:00 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Guaranty Bancshares, Inc. Announces Record Date for Conditional Special Cash Dividend

    Guaranty Bancshares, Inc. (NYSE:GNTY) (the "Company"), the parent company of Guaranty Bank & Trust, N.A. (the "Bank"), today announced that its Board of Directors has set September 19, 2025 as the record date for a conditional special cash dividend on its common stock (the "Special Dividend"). As previously announced, on June 24, 2025, the Company and the Bank entered into a Plan and Agreement of Merger (the "Merger Agreement"), with Glacier Bancorp, Inc. ("GBCI") and its wholly owned subsidiary, Glacier Bank, pursuant to which, subject to the satisfaction or waiver of certain conditions set forth in the Merger Agreement, the Company will merge with and into GBCI (the "Merger"), with GBCI

    9/9/25 4:30:00 PM ET
    $GNTY
    Major Banks
    Finance

    Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

        - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing Australian patent acceptance for the stenoparib DRP® companion diagnostic- Secured new service contract with EU biotech for Allarity Medical Laboratory TARPON SPRINGS, Fla., August 15, 2025 -- Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—today reported financial results and provided an update on operational highlights for the second quarter ended June 30, 2025. "The second quarter of 2025 marked a period

    8/15/25 4:30:00 PM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care